FDA approves eclampysia treatment for cancer patients

The Food and Drug Administration has approved an FDA-approved treatment for an estimated 30 million patients worldwide with severe, intractable, or relapsing-remitting cancer.The approval, which is effective Jan. 1, is a significant victory for eclamptive therapy for patients with advanced, life-threatening, or incurable cancer.The FDA says eclamsia is approved for patients who have been diagnosed